Global Cord Blood Corporation (CORBF)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Jul 30, 2025	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018
Market Capitalization	95	468	551	387	853	1,158
Market Cap Growth	-15.01%	-15.01%	42.45%	-54.70%	-26.31%	138.16%
Enterprise Value	-	-554	-346	-385	159	532
Last Close Price	0.71	3.85	4.53	3.18	7.02	10.10
PE Ratio	1.09	5.92	7.10	5.82	19.67	30.64
Forward PE	-	30.65	30.65	30.65	30.65	30.65
PS Ratio	0.48	2.39	3.11	2.24	5.80	7.76
PB Ratio	0.12	0.61	0.82	0.70	1.67	2.33
P/TBV Ratio	0.13	0.62	0.84	0.72	1.73	2.41
P/FCF Ratio	1.02	5.00	5.92	4.56	7.52	9.66
P/OCF Ratio	0.98	4.84	5.72	4.39	7.23	8.87
PEG Ratio	-	1.29	1.29	1.29	1.29	1.29
EV/Sales Ratio	-	-	-	-	1.08	3.56
EV/EBITDA Ratio	-	-	-	-	2.46	10.10
EV/EBIT Ratio	-	-	-	-	2.80	11.93
EV/FCF Ratio	-	-	-	-	1.40	4.44
Debt / Equity Ratio	0	0	0	0.00	-	-
Debt / EBITDA Ratio	0.00	0.00	0.00	0.01	-	-
Debt / FCF Ratio	0	0	0.00	0.01	-	-
Asset Turnover	0.15	0.15	0.15	0.18	0.16	0.17
Inventory Turnover	4.07	4.07	4.07	5.30	6.72	6.18
Quick Ratio	10.64	10.64	9.91	9.78	8.57	9.33
Current Ratio	10.73	10.73	10.05	9.93	8.64	9.42
Return on Equity (ROE)	10.99%	10.99%	12.47%	13.07%	9.03%	9.71%
Return on Assets (ROA)	4.63%	4.63%	4.50%	5.07%	3.85%	3.17%
Return on Capital (ROIC)	8.21%	8.21%	8.22%	9.55%	7.29%	5.84%
Return on Capital Employed (ROCE)	7.70%	7.70%	7.50%	8.40%	6.40%	5.20%
Earnings Yield	83.12%	16.89%	14.09%	17.20%	5.08%	3.26%
FCF Yield	98.51%	20.02%	16.90%	21.91%	13.30%	10.35%
Dividend Yield	-	-	-	-	-	0.79%
Payout Ratio	-	-	-	-	6.24%	-
Buyback Yield / Dilution	-	-	-	-0.11%	-1.75%	-63.46%
Total Shareholder Return	-	-	-	-0.11%	-1.75%	-62.67%

Updated Aug 16, 2022. Source: S&P Global Market Intelligence. Standard template. Financial Sources.